Abstract
For more than 50 years, the Food and Nutrition Board of the National Academy of Sciences has been reviewing nutrition research and defining nutrient requirements for healthy people, referred to as the recommended dietary allowances (RDA). As new nutrition research is published, the importance of vitamins as vital nutrients is underscored, and new physiologic roles and applications to human health are examined and considered with regard to updating the RDA. Each year a substantial amount of research is published on vitamins. This article examines and summarizes noteworthy research published on individual water-soluble vitamins (excluding vitamin C) in the past 12 months, provides relevant background information on these vitamins, and offers critical reviews as appropriate.
Similar content being viewed by others
References and Recommended Reading
Whitney EN, Cataldo CB, Rolfes SR: Understanding Normal and Clinical Nutrition. Belmont, CA: Wadsworth/Thompson Learning; 2002:322–328.
Bailey LB, Moyers S, Gregory III JF: Folate. In Present Knowledge in Nutrition, edn 8. Edited by Bowman BA, Russell RM. Washington, DC: ISLI Press; 2001:214–229.
Food and Nutrition Board, Institute of Medicine: Folic Acid. Dietary Reference Intakes: Thiamin, Riboflavin, Niacin, Vitamin B-6, Vitamin B-12, Pantothenic Acid, Biotin, and Choline. Washington, DC: National Academies Press; 1998:193–305.
Higdon J: An Evidence-Based Approach to Vitamins and Minerals. New York: Thieme; 2003:6–14.
Botto LD, Lisi A, Robert-Gnansia E, etal: International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005, 330:571. Retrospective cohort study with data from over 13 million births in Europe and Israel from 1988 to 1998, identifying cases of neural tube defects and policies and recommendations regarding folic acid; as well as data showing no detectable improvement in incidence of NTD resulting from issuing recommendations on folic acid supplementation.
Charles D, Ness AR, Campbell D, etal: Taking folate in pregnancy and risk of maternal breast cancer. BMJ 2004, 329:1375–1376.
Hall MH: Folic acid deficiency and congenital malformation. J Obstet Gynaecol Br Commonw 1972, 79:159–61.
Oakley GP, Mandel JS: Commentary: folic acid fortification remains an urgent health priority. BMJ 2004, 329:1376.
Shrubsole MJ, Jin F, Dai Q, etal: Dietary folate intake and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Res 2001, 61:7136–7141.
Ray JG: Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 1998, 158:2101–2106.
Nelen WL: Hyperhomocysteinaemia and human reproduction. CCLM 2001, 39:758–763.
Hoffer LI: Methods for measuring sulfur amino acid metabolism. Curr Opin Clin Nutr Metab Care 2002, 5:511–517.
Dekker GA, de Vries JI Doelitzsch PM, etal: Underlying disorders associated with severe early-onset preedampsia. Am J Obstet Gynecol 1995, 173:1042–1048.
Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists’ Collaboration. BMJ 1998, 316:894–898.
Brattstrom L: Vitamins as homocysteine-lowering agents. J Nutr 1996, 126(4 Suppl):1276S-1280S.
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 1995, 274:1049–1057.
Connor S, Ojeda L, Sexton G, et al: Diets lower in folic acid and carotenoids are associated with the coronary disease epidemic in central and eastern Europe. J Am Diet Assoc 2004, 104:1793–1799.
Lange H, Suryaprana H, De Luca G, et al: Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med 2004, 350:2673–2681.
Herrmann HC: Prevention of cardiovascular events after percutaneous coronary intervention. N Engl J Med 2004, 350:2708–2710.
Patrick TE, Powers RW, Daftary AR, et al: Homocysteine and folic acid are inversely related in black women with preeclampsia. Hypertension 2004, 43:1279–1282.
Breteler MMB: Vascular risk factors for Alzheimer’s disease: an epidemiologic perspective. Neurobiol Aging 2000, 21:153–160.
Quadri P, Fragiacomo C, Pezzati R, et al: Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 2004, 80:114–122. Recent research showing the lowest folate tertile were found to have significantly higher adjusted odds ratios for mild cognitive impairment and dementia, whereas hyperhomocysteineemia was significantly associated with dementia and Alzheimer disease.
Ghadirian A, Ananth J, Engelsmann F: Folic acid deficiency and depression. Psychosomatics 1980, 21:926–929.
Wolfersdorf M, Konig F: Serum folie acid and vitamin B-12 in depressed inpatients [in German]. Psychiatr Prax 1995, 22:162–164.
Tolmunen T, Hintikka J, Voutilainen S, et al: Association between depressive symptoms and serum concentrations of homocysteine in men: a population study. Am J Clin Nutr 2004, 80:1574–1578.
Martínez M, Henning S, Alberts D: Folate and colorectal neoplasia: relation between plasma and dietary markers of folate and adenoma recurrence. Am J Clin Nutr 2004, 79:691–697.
van Meurs JBJ, Dhonukshe-Rutten RAM, Pluijm SMF, et al: Homocysteine levels and the risk of osteoporotic fracture. BJM 2004, 350:2033–2041.
McLean RR, Jacques PF, Selhub J, et al: Homocysteine as a predictive factor for hip fracture in older persons. BJM 2004, 350:2042–2049.
Whitney EN, Cataldo CB, Rolfes SR: Understanding Normal and Clinical Nutrition. Belmont, CA: Wadsworth/Thompson Learning; 2002:310–313.
Babaei-Jadidi R, Karachalias N, Kupich C, et al: High-dose thiamine therapy counters dyslipidaemia in streptozotocininduced diabetic rats. Diabetologia 2004, 47:2235–2246.
Rivlin RS: Riboflavin. In Present Knowledge in Nutrition, edn 8. Edited by Bowman BA Russell RM. Washington, DC: ISLI Press; 2001:191–198.
Higdon J: An Evidence-Based Approach to Vitamins and Minerals. New York: Thieme; 2003:27–32.
Whitney EN, Cataldo CB, Rolfes SR: Understanding Normal and Clinical Nutrition. Belmont, CA: Wadsworth/Thompson Learning; 2002:314–316.
Schoenen J, Leneaerts M, Bastings E: High dose riboflavin as a prophylactic treatment of migraine: results of an open pilot study. Cephalalgia 1994, 14:328–329.
Schoenen J, Jacquy J, Lenaerts M: Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998, 50:466–470.
Boehnke C, Reuter U, Flach U, et al: High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol 2004, 11:475–477.
Liu J, Raine A, Venables PH, Mednick SA: Malnutrition at age 3 years and externalizing behavior problems at ages 8, 11, and 17 Years. Am J Psychiatry 2004, 161:2005–2013. Birth cohort study tracking subjects through adolescence, demonstrating malnutrition (riboflavin deficiency, protein malnutrition, and iron deficiency) in the first few years of life leads to antisocial and aggressive behavior.
Whitney EN, Cataldo CB, Rolfes SR: Understanding Normal and Clinical Nutrition. Belmont, CA: Wadsworth/Thompson Learning; 2002:316–319.
Rivlin RS: Riboflavin. In Present Knowledge in Nutrition, edn 8. Edited by Bowman BA Russell RM. Washington, DC: ISLI Press; 2001:199–206.
Higdon J: An Evidence-Based Approach to Vitamins and Minerals. New York: Thieme; 2003:15–22.
Groenen PMW, van Rooij IALM, Peer PGM, et al: Low maternal dietary intakes of iron, magnesium, and niacin are associated with spina bifida in the offspring. J Nutr 2004, 134:1516–1522.
Morris MC, Evans DA, Bienias JL, et al: Dietary niacin and the risk of incident Alzheimer’s disease and of cognitive decline J Neurol Neurosurg Psychiatry 2004, 75:1093–1099.
McCormick DB: Vitamin B-6. In Present Knowledge in Nutrition, edn 8. Edited by Bowman BA Russell RM. Washington, DC: ISLI Press; 2001:207–213.
Whitney EN, Cataldo CB, Rolfes SR: Understanding Normal and Clinical Nutrition, Belmont, CA: Wadsworth/Thompson Learning; 2002:321–322.
Higdon J: An Evidence-Based Approach to Vitamins and Minerals. New York: Thieme; 2003:48–55.
Friso S, Girell D, Martinelli N, et al: Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 2004, 79:992–998. A case control study demonstrating that low concentrations of PLP are also associated with high CRP concentrations; and low PLP and elevated hsCRP and fibrinogen are related to higher risk of coronary artery disease.
Higdon J: An Evidence-Based Approach to Vitamins and Minerals. New York: Thieme; 2003:56–64.
Whitney EN, Cataldo CB, Rolfes SR: Understanding Normal and Clinical Nutrition. Belmont, CA: Wadsworth/Thompson Learning; 2002:328–330.
Stabler SP: Vitamin B-12. In Present Knowledge in Nutrition, edn 8. Edited by Bowman BA Russell RM. Washington, DC: ISLI Press; 2001:230–240.
Kirke PN, Molloy AM, Daly LE, et al.: Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993, 86:703–708.
Groenen PMW, van Rooij IALM, Peer PGM, et al: Marginal maternal vitamin B12 status increases the risk of offspring with spina bifida. Am J Obstet Gynecol 2004, 191:11–17.
Tucker KL, Hannan MT, Qiao N, et al: Low plasma vitamin B12 is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res 2005, 20:152–158. Framingham Offspring Osteoporosis Study analysis demonstrates that men and women with vitamin B12 levels lower than 148 pM had significantly lower average BMD (P < 0.05).
Stone KL, Bauer DC, Sellmeyer D, Cummings SR: Low serum vitamin bB 12 levels are associated with increased hip bone loss in older women: a prospective study. J Clin Endocrinol Metab 2004, 89:1217–1221.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bruno, E.J., Ziegenfuss, T.N. Water-soluble vitamins: Research update. Curr Sports Med Rep 4, 207–213 (2005). https://doi.org/10.1007/s11932-005-0037-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11932-005-0037-1